These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 22710977)
1. Predicting post-stroke infections and outcome with blood-based immune and stress markers. Meisel A; Meisel C; Harms H; Hartmann O; Ulm L Cerebrovasc Dis; 2012; 33(6):580-8. PubMed ID: 22710977 [TBL] [Abstract][Full Text] [Related]
2. Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Harms H; Reimnitz P; Bohner G; Werich T; Klingebiel R; Meisel C; Meisel A Cerebrovasc Dis; 2011; 32(6):552-60. PubMed ID: 22104620 [TBL] [Abstract][Full Text] [Related]
3. [Immune responses and neuroimmune modulation in the pathogenesis of acute ischemic stroke and poststroke infections]. Papp V; Molnár T; Bánáti M; Illés Z Ideggyogy Sz; 2010 Jul; 63(7-8):232-46. PubMed ID: 20812451 [TBL] [Abstract][Full Text] [Related]
4. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604 [TBL] [Abstract][Full Text] [Related]
5. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Klehmet J; Harms H; Richter M; Prass K; Volk HD; Dirnagl U; Meisel A; Meisel C Neuroscience; 2009 Feb; 158(3):1184-93. PubMed ID: 18722511 [TBL] [Abstract][Full Text] [Related]
6. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Urra X; Cervera A; Villamor N; Planas AM; Chamorro A Neuroscience; 2009 Feb; 158(3):1174-83. PubMed ID: 18619524 [TBL] [Abstract][Full Text] [Related]
7. Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage. Zhang X; Lu XM; Huang LF; Ye H Peptides; 2012 Feb; 33(2):336-41. PubMed ID: 22286033 [TBL] [Abstract][Full Text] [Related]
8. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K; Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228 [TBL] [Abstract][Full Text] [Related]
9. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981 [TBL] [Abstract][Full Text] [Related]
10. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506 [TBL] [Abstract][Full Text] [Related]
11. Impact of innate inflammation in population studies. Elkind MS Ann N Y Acad Sci; 2010 Oct; 1207():97-106. PubMed ID: 20955432 [TBL] [Abstract][Full Text] [Related]
12. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Nickel CH; Ruedinger J; Misch F; Blume K; Maile S; Schulte J; Köhrle J; Hartmann O; Giersdorf S; Bingisser R Acad Emerg Med; 2011 Aug; 18(8):851-9. PubMed ID: 21843221 [TBL] [Abstract][Full Text] [Related]
13. Stroke biomarkers: Can they help us to guide stroke thrombolysis? Montaner J Drug News Perspect; 2006 Nov; 19(9):523-32. PubMed ID: 17220957 [TBL] [Abstract][Full Text] [Related]
14. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Kolditz M; Halank M; Schulte-Hubbert B; Bergmann S; Albrecht S; Höffken G Respir Med; 2012 Sep; 106(9):1320-8. PubMed ID: 22732597 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke. Lukasik M; Dworacki G; Kufel-Grabowska J; Watala C; Kozubski W Thromb Haemost; 2012 Feb; 107(2):346-55. PubMed ID: 22234746 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Berres ML; Schnyder B; Yagmur E; Inglis B; Stanzel S; Tischendorf JJ; Koch A; Winograd R; Trautwein C; Wasmuth HE Liver Int; 2009 Apr; 29(4):536-43. PubMed ID: 18795898 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke. Katan M; Elkind MS Expert Rev Neurother; 2011 Feb; 11(2):225-39. PubMed ID: 21306210 [TBL] [Abstract][Full Text] [Related]
18. Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Lukaszewicz AC; Grienay M; Resche-Rigon M; Pirracchio R; Faivre V; Boval B; Payen D Crit Care Med; 2009 Oct; 37(10):2746-52. PubMed ID: 19707128 [TBL] [Abstract][Full Text] [Related]
19. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953 [TBL] [Abstract][Full Text] [Related]
20. [Severe stroke: prognosis, intensive care admission and withhold and withdrawal treatment decisions]. Crozier S; Santoli F; Outin H; Aegerter P; Ducrocq X; Bollaert PÉ Rev Neurol (Paris); 2011; 167(6-7):468-73. PubMed ID: 21565374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]